Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape.

Santosa S, Jensen MD.

Horm Mol Biol Clin Investig. 2014 Oct;20(1):15-23. doi: 10.1515/hmbci-2014-0029. Review.

2.

An update on male hypogonadism therapy.

Surampudi P, Swerdloff RS, Wang C.

Expert Opin Pharmacother. 2014 Jun;15(9):1247-64. doi: 10.1517/14656566.2014.913022. Epub 2014 Apr 23.

3.

Lowered testosterone in male obesity: mechanisms, morbidity and management.

Fui MN, Dupuis P, Grossmann M.

Asian J Androl. 2014 Mar-Apr;16(2):223-31. doi: 10.4103/1008-682X.122365. Review.

4.

Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old.

Tavares AB, Micmacher E, Biesek S, Assumpção R, Redorat R, Veloso U, Vaisman M, Farinatti PT, Conceição F.

Int J Endocrinol. 2013;2013:942030. doi: 10.1155/2013/942030. Epub 2013 Dec 8.

5.

Neural growth hormone implicated in body weight sex differences.

Bonthuis PJ, Rissman EF.

Endocrinology. 2013 Oct;154(10):3826-35. doi: 10.1210/en.2013-1234. Epub 2013 Jul 16.

6.

Cardiometabolic risks during anabolic hormone supplementation in older men.

He J, Bhasin S, Binder EF, Yarasheski KE, Castaneda-Sceppa C, Schroeder ET, Roubenoff R, Chou CP, Azen SP, Sattler FR.

Obesity (Silver Spring). 2013 May;21(5):968-75. doi: 10.1002/oby.20081.

7.

Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Surampudi PN, Wang C, Swerdloff R.

Int J Endocrinol. 2012;2012:625434. doi: 10.1155/2012/625434. Epub 2012 Mar 14.

8.

Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P.

Endocr Rev. 2012 Jun;33(3):314-77. doi: 10.1210/er.2012-1002. Epub 2012 Mar 20. Review.

9.

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Bredella MA, Lin E, Brick DJ, Gerweck AV, Harrington LM, Torriani M, Thomas BJ, Schoenfeld DA, Breggia A, Rosen CJ, Hemphill LC, Wu Z, Rifai N, Utz AL, Miller KK.

Eur J Endocrinol. 2012 Apr;166(4):601-11. doi: 10.1530/EJE-11-1068. Epub 2012 Jan 24.

10.

Lean mass predicts hip geometry in men and women with non-insulin-requiring type 2 diabetes mellitus.

Moseley KF, Dobrosielski DA, Stewart KJ, Sellmeyer DE, Jan De Beur SM.

J Clin Densitom. 2011 Jul-Sep;14(3):332-9. doi: 10.1016/j.jocd.2011.04.007. Epub 2011 Jun 11.

11.

The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Saad F, Gooren LJ.

J Obes. 2011;2011. pii: 471584. doi: 10.1155/2011/471584. Epub 2010 Aug 10.

12.

Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.

Münzer T, Harman SM, Sorkin JD, Blackman MR.

J Clin Endocrinol Metab. 2009 Oct;94(10):3833-41. doi: 10.1210/jc.2009-1275. Epub 2009 Jul 14.

13.

Testosterone and growth hormone improve body composition and muscle performance in older men.

Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R, Azen SP.

J Clin Endocrinol Metab. 2009 Jun;94(6):1991-2001. doi: 10.1210/jc.2008-2338. Epub 2009 Mar 17.

14.

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

Ann Intern Med. 2008 Nov 4;149(9):601-11.

15.

Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial.

Attallah H, Friedlander AL, Nino-Murcia M, Hoffman AR.

PLoS Clin Trials. 2007 May 4;2(5):e21.

Supplemental Content

Support Center